EEMCO guidance for the efficacy assessment of antiperspirants and deodorants.
about
Clinical trial of pin-point photodynamic therapy using an optic fiber for the improvement of enlarged facial pores: a case study.Effects of various parameters of the 1064 nm Nd:YAG laser for the treatment of enlarged facial pores.Effects of Q-switched and long-pulsed 1064 nm Nd:YAG laser on enlarged facial pores.Treatment of enlarged pores with the quasi long-pulsed versus Q-switched 1064 nm Nd:YAG lasers: A split-face, comparative, controlled study.Deodorants and antiperspirants affect the axillary bacterial community.Treatment of dilated pores with 1410-nm fractional erbium-doped fiber laser.The conundrum of skin pores in dermocosmetology.The skin landscape in diabetes mellitus. Focus on dermocosmetic management.Deodorant effects of a sage extract stick: Antibacterial activity and sensory evaluation of axillary deodorancy.Influence of applied volume on efficacy of 3-minute surgical reference disinfection method prEN 12791Sweaty skin, background and assessments.Critical assessment of diabetic xerosis.Sweating on the palm and sole: physiological and clinical relevance.Thermoregulatory vs. event sweating--comparison of clinical methodologies, physiology and results.Working Up a Good Sweat - The Challenges of Standardising Sweat Collection for Metabolomics Analysis.Influence of climatic conditions on antiperspirant efficacy determined at different test areas.Sebum output as a factor contributing to the size of facial pores.Automatic facial pore analysis system using multi-scale pore detection.Effective axillary malodour reduction by polyquaternium-16-containing deodorants.EEMCO guidance for the assessment of hair shedding and alopecia.
P2860
Q33383980-CEC05741-CE36-4CEF-BC4D-F3E8AF81800DQ33397752-C6A27B51-D928-4F2E-AF69-765D9E2937DAQ33515779-418F4D0B-81B3-496D-A01F-96DA3E6A764BQ35025029-FA655212-C3C9-406B-89E3-83EF322A136BQ35215939-81B536FF-41CD-4AE1-8AE0-09FF0FD4CABDQ35554336-4A90DBBA-9716-44A6-91DC-82FC3173C345Q35986838-CE975B66-6105-4A6D-A451-CAAB437D9AD6Q36857213-60945956-3C96-445C-AE75-3931345DDB91Q37498207-B09D3153-70E7-4D93-9899-3389FAFFA1CCQ37701981-1399BBE2-343A-40AC-9E59-2CD450029EFEQ38011242-E0797AB7-7D57-4E74-BAD3-A32EAF08F2D9Q38093259-3CDAB723-45D5-4586-B7B3-4D1B081C4479Q38430637-EC2376D0-AACD-4F1E-B16B-E087B03C2E80Q40673574-747DE6A9-3585-489F-BF20-6946ADACEE3AQ41303216-01EB8FC7-D63F-4CC7-B09F-1B3913A85B26Q43645421-79241852-4166-4C3B-B6B5-3C68E194CCEAQ47317907-AA1B0AEA-274B-435E-AEDF-6E6F36435E59Q51114146-D95999F7-7837-4C3A-AFDB-DAE5FE823E26Q53040222-2419F987-44AA-4046-8FF4-67103835B074Q53630975-9186E692-7B5C-4C32-A336-05217BCBEF47
P2860
EEMCO guidance for the efficacy assessment of antiperspirants and deodorants.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
EEMCO guidance for the efficacy assessment of antiperspirants and deodorants.
@ast
EEMCO guidance for the efficacy assessment of antiperspirants and deodorants.
@en
type
label
EEMCO guidance for the efficacy assessment of antiperspirants and deodorants.
@ast
EEMCO guidance for the efficacy assessment of antiperspirants and deodorants.
@en
prefLabel
EEMCO guidance for the efficacy assessment of antiperspirants and deodorants.
@ast
EEMCO guidance for the efficacy assessment of antiperspirants and deodorants.
@en
P2093
P356
P1476
EEMCO guidance for the efficacy assessment of antiperspirants and deodorants.
@en
P2093
P304
P356
10.1159/000072072
P577
2003-09-01T00:00:00Z